IMIPENEM-CILASTATIN IN PEDIATRIC-PATIENTS - AN OVERVIEW OF SAFETY AND EFFICACY IN STUDIES CONDUCTED IN THE UNITED-STATES

被引:18
作者
AHONKHAI, VI
CYHAN, GM
WILSON, SE
BROWN, KR
机构
关键词
D O I
10.1097/00006454-198911000-00002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:740 / 744
页数:5
相关论文
共 31 条
[1]  
AHONKHAI VI, 9TH INT C INF PAR DI
[2]   IMIPENEM CILASTATIN FOR THE TREATMENT OF INFECTIONS IN HOSPITALIZED CHILDREN [J].
ALPERT, G ;
DAGAN, R ;
CONNOR, E ;
CAMPOS, JM ;
BLOH, AM ;
POWELL, KR ;
PLOTKIN, SA .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1985, 139 (11) :1153-1156
[3]  
BIRNBAUM J, 1985, AM J MED, V78, P3, DOI 10.1016/0002-9343(85)90097-X
[4]   IMIPENEM-CILASTATIN AS INITIAL THERAPY FOR FEBRILE CANCER-PATIENTS [J].
BODEY, GP ;
ALVAREZ, ME ;
JONES, PG ;
ROLSTON, KVI ;
STEELHAMMER, L ;
FAINSTEIN, V .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (02) :211-214
[5]   THE EFFECT OF IMIPENEM CILASTATIN ON THE AEROBIC FECAL FLORA OF CHILDREN [J].
BORDERON, JC ;
RASTEGAR, A ;
LAUGIER, J ;
GOLD, F .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 :121-125
[6]   SAFETY AND TOLERANCE COMPARISON OF IMIPENEM-CILASTATIN TO CEPHALOTHIN AND CEFAZOLIN [J].
CALANDRA, GB ;
RICCI, FM ;
WANG, C ;
BROWN, KR .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 12 :125-131
[7]   REVIEW OF ADVERSE EXPERIENCES AND TOLERABILITY IN THE 1ST 2,516 PATIENTS TREATED WITH IMIPENEM CILASTATIN [J].
CALANDRA, GB ;
BROWN, KR ;
GRAD, LC ;
AHONKHAI, VI ;
WANG, C ;
AZIZ, MA .
AMERICAN JOURNAL OF MEDICINE, 1985, 78 (6A) :73-78
[8]   THE SAFETY PROFILE OF IMIPENEM CILASTATIN - WORLDWIDE CLINICAL-EXPERIENCE BASED ON 3470 PATIENTS [J].
CALANDRA, GB ;
WANG, C ;
AZIZ, M ;
BROWN, KR .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 :193-202
[9]   INVITRO ACTIVITY OF IMIPENEM AGAINST 100 STRAINS OF SEROTYPE-B AND NONTYPABLE HEMOPHILUS-INFLUENZAE, INCLUDING STRAINS RESISTANT TO AMPICILLIN, CHLORAMPHENICOL OR BOTH [J].
CAMPOS, JM ;
GILL, CJ ;
AHONKHAI, VI .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 16 (05) :549-554
[10]  
ENGLEHARD D, 1986, PEDIATR PHARMACOL, V5, P273